IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing

IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing




IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing

IQVIA recognized in IDC MarketScape™ for its data and analytics capabilities and growing suite of software platforms

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, was judged a Leader by International Data Corporation (IDC) in its 2021 MarketScapeTM focused on the Worldwide Life Science Sales and Marketing Business Process Outsourcing (BPO) Pharma space. IDC reached its conclusion based on in-depth and rigorous analysis utilized in its MarketScape research.

“IQVIA continues to provide the pharmaceutical industry real world solutions with its BPO offerings,” said Michael Townsend, research director, Life Sciences commercial Strategies, IDC Health Insights. “As a designated Leader in the field, IQVIA is well placed to enable companies looking for improved outcomes, growth and productivity through BPO services.”

IQVIA’s strong position within the Leaders classification was illustrated by its placement on IDC’s Capabilities and Strategies MarketScape axis. Among IQVIA’s strengths, IDC observed it was well placed to use its data and analytics capabilities with a growing suite of software platforms and services that include: OneKey provider reference solutions, prescription data solutions, and Orchestrated Customer Engagement (OCE), rounding out its life science data and consulting practices.

IDC’s MarketScape also recognized IQVIA’s Human Data Science Cloud, which enables cloud-based harmonization and globalization of internal and external life science sales and marketing data. The assessment also noted IQVIA demonstrated state-of-the-art solutions that could be implemented and maintained by skilled workers virtually anywhere in the world, augmented by technologies such as cloud computing, AI, analytics and mobile devices.

“IDC continues to recognize IQVIA as a leading provider of BPO solutions and services,” said Kevin Knightly, president, Technology & Commercial Solutions for IQVIA. “We remain committed to using our global data and analytics capabilities to provide our clients with real-world solutions that produce tangible results.”

IDC analysts base individual vendor MarketScape scores and vendor positions on detailed surveys and interviews with the vendors, publicly available information, and end-user experiences. This level of in-depth analysis provides an accurate and consistent assessment of each vendor’s characteristics, behavior, and capabilities.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 77,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Contacts

Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)

+1.973.316.3828

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)

+1.484.567.6732